Front page

Finnish Social and Health Data Permit Authority Findata

We grant permits for the secondary use of social and health care data and improve data protection for individuals. After granting the permit we compile, combine and pre-process it and offer tools for analysing.
Data sources
See which data controllers’ data are available, who grants the permits and where you can find data descriptions.
Data
Apply for a permit
Submit an application when the data needed is from several public data controllers, the private sector or from Kanta Services.
Permits
Information for citizens
Learn what your data is used for, what your rights under the GDPR are, and how we take care of your privacy.
Data protection



News

A team of researchers is bridging the gap between clinical research and registry studies with the aim of reinventing cancer drug research

21.07.2022
Heidi Loponen, Senior Scientific Consultant at MedEngine Oy, uses register data in… Read more A team of researchers is bridging the gap between clinical research and registry studies with the aim of reinventing cancer drug research

The range of Kanta Services materials for which secondary use permits are available is expanding

09.06.2022
It has been possible to apply for permits to use health and… Read more The range of Kanta Services materials for which secondary use permits are available is expanding

Researchers analyse the patient and registry data of thousands of diabetics in order to improve their quality-of-life – around a third of type 1 diabetics suffer from kidney disease

12.05.2022
The FinnDiane follow-up study, which has been ongoing for more than 20… Read more Researchers analyse the patient and registry data of thousands of diabetics in order to improve their quality-of-life – around a third of type 1 diabetics suffer from kidney disease

We are renewing our website. Unfortunately, some pages have not yet been translated into English.

A team of researchers is bridging the gap between clinical research and registry studies with the aim of reinventing cancer drug research

21.07.2022
Heidi Loponen, Senior Scientific Consultant at MedEngine Oy, uses register data in a study aimed at validating the usefulness of a mathematical model for cancer treatments. “If this model proves effective, research data on cancer treatment can be produced with a smaller number of patients and more ethically in the future,” explains Loponen. Read more A team of researchers is bridging the gap between clinical research and registry studies with the aim of reinventing cancer drug research

Application and decision statistics 26 September 2022

831

Applications

54 % Data Permits
38 % Amendments
8 % Data Requests

623

Decisions

76 % positive
23 % lapsed
1 % administrative transfer

208

Open

43 % in process
16 % pre-screening
41 % pending

For more information about the handling process, see Permits

Application processing

Unfortunately we have a queue, see the estimated queuing times below.

Data permits: approximately 12 months, pre-screened approximately 1-2 months
Data requests: approximately 5 months
Amendment applications: approximately 1 month